Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials
Abstract Purpose: Response Evaluation Criteria in Solid Tumors (RECIST) evaluation does not take into account the pretreatment tumor kinetics and may provide incomplete information about experimental drug activity. Tumor growth rate (TGR) allows for a dynamic and quantitative assessment of the tumor...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2013
|
| 在线阅读: | https://doi.org/10.1158/1078-0432.ccr-13-2098 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|